InvestorsHub Logo
Followers 68
Posts 506
Boards Moderated 0
Alias Born 08/14/2020

Re: None

Friday, 11/13/2020 2:08:26 AM

Friday, November 13, 2020 2:08:26 AM

Post# of 44690
RELIEF, WITH PARTNER NEURORX, ANNOUNCES ENROLLMENT OF 150 PATIENTS IN PHASE 2B/3 TRIAL OF RLF-100™ FOR CRITICAL COVID-19 WITH RESPIRATORY FAILURE

13 November 2020



https://relieftherapeutics.com/newsblog/123-relief-therapeutics-and-neurorx-announce-continuation-of-rlf-100-trial-for-treatment-of-covid-19-respiratory-failure-trial-is-on-track-to-complete-enrollment-in-2022

Disclaimer

All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.